High-density lipoprotein mimetics: promises and challenges

被引:27
|
作者
Sviridov, Dmitri [1 ]
Remaley, Alan T. [2 ]
机构
[1] Baker IDI Heart & Diabet Inst, Lab Lipoprot & Atherosclerosis, Melbourne, Vic 3004, Australia
[2] NHLBI, Lipoprot Sect, NIH, Bethesda, MD 20892 USA
基金
英国医学研究理事会;
关键词
apolipoproteins; atherosclerosis; cholesterolmetabolism; lipoprotein metabolism; peptides; APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; PEPTIDE; 4F; ANTIINFLAMMATORY PROPERTIES; CORONARY ATHEROSCLEROSIS; REDUCES ATHEROSCLEROSIS; AMPHIPATHIC PEPTIDES; PLASMA-CLEARANCE; LESION FORMATION; OXIDIZED LIPIDS;
D O I
10.1042/BJ20150832
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The concept of lipoprotein mimetics was developed and extensively tested in the last three decades. Most lipoprotein mimetics were designed to recreate one or several functions of high-density lipoprotein (HDL) in the context of cardiovascular disease; however, the application of this approach is much broader. Lipoprotein mimetics should not just be seen as a set of compounds aimed at replenishing a deficiency or dysfunctionality of individual elements of lipoprotein metabolism but rather as a designer concept with remarkable flexibility and numerous applications in medicine and biology. In the present review, we discuss the fundamental design principles used to create lipoprotein mimetics, mechanisms of their action, medical indications and efficacy in animal models and human studies.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 50 条
  • [41] Detection of oxidized high-density lipoprotein
    Matsunaga, T
    Koyama, I
    Hokari, S
    Komoda, T
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 781 (1-2): : 331 - 343
  • [42] HIGH-DENSITY LIPOPROTEIN PARTICLES IN OCTOGENARIANS
    LUC, G
    BARD, JM
    LUSSIERCANCAN, S
    PARRA, HJ
    FRUCHART, JC
    DAVIGNON, J
    ARTERIOSCLEROSIS, 1989, 9 (05): : A750 - A750
  • [43] CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN AND DANAZOL
    ALLEN, JK
    FRASER, IS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (01): : 149 - 152
  • [44] HYPERBILIRUBINEMIA AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
    NANJI, AA
    REDDY, S
    ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) : 786 - 786
  • [45] miRNAs and High-Density Lipoprotein metabolism
    Baldan, Angel
    Vallim, Thomas Q. de Aguiar
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (12): : 2053 - 2061
  • [46] High-density lipoprotein and innate immunity
    Nielsen, Marianne Jensby
    Nielsen, Lars Bo
    Moestrup, Soroi K.
    FUTURE LIPIDOLOGY, 2006, 1 (06): : 729 - 734
  • [47] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN DIABETES
    MATTOCK, MB
    FULLER, JH
    BRITISH MEDICAL JOURNAL, 1978, 2 (6153): : 1717 - 1717
  • [48] The paradox of dysfunctional high-density lipoprotein
    Ansell, Benjamin J.
    Fonarow, Gregg C.
    Fogelman, Alan M.
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) : 427 - 434
  • [49] Recombinant High-Density Lipoprotein Formulations
    Vucic, Esad
    Rosenson, Robert S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (01) : 81 - 87
  • [50] Dysfunctional High-Density Lipoprotein and Atherosclerosis
    Shawn Ragbir
    John A. Farmer
    Current Atherosclerosis Reports, 2010, 12 : 343 - 348